Activity from announced rounds
Foresite Capital is a healthcare investment firm identified by Abcuro and in its own Thyme Care portfolio record.
Abcuro develops immunotherapies targeting pathogenic cytotoxic T cells. Thyme Care combines oncology care teams with technology, while Khartis develops oral medicines for immune and chronic diseases. The company histories distinguish care delivery from experimental drug development.
Thyme Care combines oncology-trained care teams and technology to support people through cancer treatment while helping health plans and providers improve outcomes and control costs. It monitors patient needs between appointments, coordinates with oncologists and connects members to clinical, practical and social support.
Clinical-stage immunotherapies targeting pathogenic cytotoxic T cells in autoimmune disease.
Develops oral small molecule therapies for immunological and chronic diseases
Offers accelerated, affordable training for healthcare careers
Advancing next-generation therapeutics for migraine and other headache disorders
Develops therapies for neurodegenerative diseases.
Provides accessible, insurance-covered services in all 50 states for women's healthcare
Develops medicines targeting historically undruggable protein targets in cancer